Facebook
Twitter
LinkedIn
Forward
Head & Neck Oncology Symposium
The incidence of head and neck cancer in the United States is expected to increase by 12% from 2020 till 2030 (CDC USCS Data). While head and neck cancer accounts for only 4% of all cancers in the United States, the extensive treatment modalities, severe impact on daily living, and high recurrence rate make head and neck cancer one of the most complex oncologic subspecialties to develop within the hospital (American Cancer Society). Clinicians need up to date knowledge of care management for patients with head and neck cancer. We will educate on updates in surgical advances, chemotherapy and immunotherapy developments, clinical trials, radiation therapy, and technology evolution for reconstruction. In addition to covering clinical advancements, we will educate on the multidisciplinary team that is vital to the treatment of head and neck cancer patients. The responsibilities of surgeons, radiation oncologists, medical oncologists, pathologists, social workers, nurse navigators, speech and language pathologists, and maxillofacial prosthodontics will be covered at length with panels teaching how to create highly-effective and collaborative multidisciplinary teams.
Target Audience
Clinicians caring for head and neck cancer patients, including but not limited to: ENT, Oral and Maxillofacial Surgeons, Endocrinologists, Speech Language Pathologists, Nurse Navigators, Radiation Oncologists, Medical Oncologists, Pathologists, Head & Neck Surgeons, Dentists, Medical Residents, Social Workers, Fellows in Oncologic Specialties.
Learning Objectives
Upon conclusion of this symposium, learners should be able to:
- Diagnose, manage, and treat salivary and neoplasms cancers (head and neck cancer) with the multidisciplinary care team to improve patient experience and outcomes.
- Apply new advancements in the care management of oral and oropharyngeal cancers including multidisciplinary treatment and collaboration.
- Integrate survivorship into the post treatment algorithm to ensure psychosocial and quality of life endpoints are incorporated into the patients care.
Please click here for more information regarding the venue
Travel
Lodging accommodations need to be booked directly with Wild Dunes Resort. Please use the following link for access to the discounted group block rate of $299/night plus tax. It is important to make hotel reservations by 10/10/2023 as the discounted rate will end thereafter. If you have trouble with the booking website, please call the Toll Free Reservation Line: 866-359-5593, Option 2. Inform the customer service representative that you are booking through the Head & Neck Cancer Symposium Group Rate.
Jeffrey Houlton, MD
Alexandra Hoffman, MHA
Kimberly Aderhold, DO
James Bekeny, MD
Lawrence Brecht, DDS
Ken Byrd, MD
Hannah Cornett, MS, CCC-SLP, BCS-S
Betsy Davis, DMD, MS
Paul Davis, MD
Terry Day, MD
Brian Gross, MD, FACS
Steven Hong, MD
Joshua Hornig, MD
Peter Horwich, MD
Jeffrey Houlton, MD
Azeem Kaka, MD
Andrew Kennedy, MD, FACRO
Eric Lentsch, MD
Bill Lydiatt, MD, EMBA
Andrew Nemechek
David Neskey, MD
Brad Neville, DDS
Seerat Poonia, MD
Jordan Rawl, MD
Michelle Ruse
Russell Smith, MD
Accreditation:
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of HCA Healthcare Continental Division and HCA Healthcare South Atlantic Division. HCA Healthcare Continental Division is accredited by the ACCME to provide continuing medical education for physicians
Credit Designation:
The HCA Healthcare Continental Division designates this live activity for a maximum of 8.0 AMA PRA Category 1TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Commercial Support:
This Activity was developed without support from any ineligible company.*The ACCME defines ineligible companies as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Note: The ACCME does not consider providers of clinical service directly to patients to be commercial interests – unless the provider of clinical services is owned, or controlled by, and ACCME defined ineligible company.
Disclosure:
The HCA Healthcare Continental Division is committed to providing CME that is balanced, objective, and evidenced-based. In accordance with the Accreditation Council for Continuing Medical Education Standards for Integrity and Independence all parties involved in content development are required to disclose all conflicts of interest with ACCME defined ineligible companies. The HCA Healthcare Continental Division has identified, reviewed, and mitigated all conflicts of interest that speakers, authors, course directors, planners, peer reviewers, or relevant staff disclose prior to the delivery of any educational activity. The CME planning committee who are in a position to control the content of this CME Activity, have no relevant financial relationships with ineligible companies to disclose.
Available Credit
- 8.00 AMA PRA Category 1 Credit™HCA Healthcare Continental Division is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
HCA Healthcare Continental Division designates this for a maximum of 8.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. - 8.00 Attendance
The registration fee includes tuition, electronic course syllabus, continental breakfasts, break refreshments, and lunch.
Although it is not HCA Healthcare Continental Division (CME) policy to limit the number of registrants for a course, conference room facilities may necessitate closing of enrollment; therefore, early registration is advised. Enrollment for this program is limited.
HCA Healthcare Continental Division (CME) reserves the right to cancel or postpone any course due to unforeseen circumstances. In the unlikely event HCA Healthcare Continental Division (CME) must cancel or postpone this course, HCA Healthcare Continental Division (CME) will refund the registration fee, but is not responsible for any related costs, charges, or expenses to participants, including fees assessed by airline/travel/lodging agencies.
CANCELLATION POLICY
If you cancel your participation in this course, your registration fee, less a $75 administration fee, will be refunded when written notification is received by HCA Healthcare Continental Division (CME) before, September 29, 2023 (email: Stacy.Weiss@healthonecares.com). No refunds will be made on or after September 29, 2023. Canceled registrations are non-transferable.